Study shows ENDUR-ACIN® improves lipid profiles in patients with dyslipidemia, while “flush free” niacin has no effect
Highlights ENDUR-ACIN® (1,500 mg/day) significantly improves lipid profiles in patients with mild-to-moderate dyslipidemia. ENDUR-ACIN® shows an intermediate release and absorption rate over 6 hours. Inositol hexanicotinate (so-called flush-free niacin) shows...